Abram, Débora Moitinho <br/><br/>
The modulation of enzyme indoleamine 2,3-dioxygenase from dendritic cells for the treatment of type 1 diabetes mellitus.  [electronic resource] 

 -  Drug design, development and therapy  2017 
 - 2171-2178 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1177-8881 
<br/><br/><label>Standard No.: </label>10.2147/DDDT.S135367  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Dendritic Cells--enzymology<br/>Diabetes Mellitus, Type 1--immunology<br/>Humans<br/>Indoleamine-Pyrrole 2,3,-Dioxygenase--immunology